ID ITB4_MOUSE Reviewed; 1818 AA. AC A2A863; A2A865; A2A866; Q6PCS0; Q8R3J1; Q91W15; DT 07-JUL-2009, integrated into UniProtKB/Swiss-Prot. DT 20-FEB-2007, sequence version 1. DT 27-MAR-2024, entry version 146. DE RecName: Full=Integrin beta-4; DE AltName: CD_antigen=CD104; DE Flags: Precursor; GN Name=Itgb4; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RX PubMed=8359687; DOI=10.1016/0378-1119(93)90421-x; RA Kennel S.J., Foote L.J., Cimino L., Rizzo M.G., Chang L.Y., Sacchi A.; RT "Sequence of a cDNA encoding the beta 4 subunit of murine integrin."; RL Gene 130:209-216(1993). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 124-1818 (ISOFORM 2). RC STRAIN=Czech II, and FVB/N; TISSUE=Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1071 AND SER-1470, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Kidney, Lung, and Pancreas; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Integrin alpha-6/beta-4 is a receptor for laminin. It plays a CC critical structural role in the hemidesmosome of epithelial cells. Is CC required for the regulation of keratinocyte polarity and motility. CC ITGA6:ITGB4 binds to NRG1 (via EGF domain) and this binding is CC essential for NRG1-ERBB signaling. ITGA6:ITGB4 binds to IGF1 and this CC binding is essential for IGF1 signaling. ITGA6:ITGB4 binds to IGF2 and CC this binding is essential for IGF2 signaling. CC {ECO:0000250|UniProtKB:P16144}. CC -!- SUBUNIT: Heterodimer of an alpha and a beta subunit. Beta-4 associates CC with alpha-6. Interacts (via cytoplasmic region) with COL17A1 (via CC cytoplasmic region). Interacts (via cytoplasmic region) with DST CC isoform 3 (via N-terminus). Interacts (via cytoplasmic domain) with DST CC (via N-terminus). Interacts with RAC1. ITGA6:ITGB4 is found in a CC ternary complex with NRG1 and ERBB3. ITGA6:ITGB4 is found in a ternary CC complex with IGF1 and IGF1R. ITGA6:ITGB4 interacts with IGF2. CC {ECO:0000250|UniProtKB:P16144}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I CC membrane protein {ECO:0000250}. Cell membrane {ECO:0000250}; Lipid- CC anchor {ECO:0000250}. Cell junction, hemidesmosome {ECO:0000250}. CC Note=Colocalizes with DST at the leading edge of migrating CC keratinocytes. {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=A2A863-1; Sequence=Displayed; CC Name=2; CC IsoId=A2A863-2; Sequence=VSP_037636; CC Name=3; CC IsoId=A2A863-3; Sequence=VSP_037636, VSP_037637; CC -!- DOMAIN: The fibronectin type-III-like domains bind BPAG1 and plectin CC and probably also recruit BP230. {ECO:0000250}. CC -!- DOMAIN: The VWFA domain (or beta I domain) contains three cation- CC binding sites: the ligand-associated metal ion-binding site (LIMBS or CC SyMBS), the metal ion-dependent adhesion site (MIDAS), and the adjacent CC MIDAS site (ADMIDAS). This domain is also part of the ligand-binding CC site. {ECO:0000250|UniProtKB:P05106}. CC -!- PTM: Palmitoylated by DHHC3 at several cysteines of the membrane- CC proximal region, enhancing stability and cell surface expression. CC Palmitoylation also promotes secondary association with tertaspanins CC (By similarity). {ECO:0000250|UniProtKB:P16144}. CC -!- SIMILARITY: Belongs to the integrin beta chain family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL607108; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL645647; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC006632; AAH06632.1; -; mRNA. DR EMBL; BC025194; AAH25194.1; -; mRNA. DR EMBL; BC059192; AAH59192.1; -; mRNA. DR PIR; JN0786; JN0786. DR RefSeq; XP_006532635.1; XM_006532572.3. [A2A863-1] DR RefSeq; XP_006532636.1; XM_006532573.3. [A2A863-3] DR RefSeq; XP_006532637.1; XM_006532574.2. DR AlphaFoldDB; A2A863; -. DR SMR; A2A863; -. DR BioGRID; 228715; 11. DR ComplexPortal; CPX-3120; integrin alpha6-beta4 complex. DR IntAct; A2A863; 2. DR STRING; 10090.ENSMUSP00000127604; -. DR GlyCosmos; A2A863; 5 sites, No reported glycans. DR GlyGen; A2A863; 6 sites, 1 O-linked glycan (1 site). DR iPTMnet; A2A863; -. DR PhosphoSitePlus; A2A863; -. DR MaxQB; A2A863; -. DR PaxDb; 10090-ENSMUSP00000102068; -. DR PeptideAtlas; A2A863; -. DR ProteomicsDB; 301690; -. [A2A863-1] DR ProteomicsDB; 301691; -. [A2A863-2] DR ProteomicsDB; 301692; -. [A2A863-3] DR Antibodypedia; 3934; 1159 antibodies from 44 providers. DR DNASU; 192897; -. DR Ensembl; ENSMUST00000068981.13; ENSMUSP00000070811.7; ENSMUSG00000020758.16. [A2A863-2] DR Ensembl; ENSMUST00000106458.2; ENSMUSP00000102066.2; ENSMUSG00000020758.16. [A2A863-1] DR Ensembl; ENSMUST00000106460.9; ENSMUSP00000102068.3; ENSMUSG00000020758.16. [A2A863-3] DR Ensembl; ENSMUST00000106461.8; ENSMUSP00000102069.2; ENSMUSG00000020758.16. [A2A863-1] DR GeneID; 192897; -. DR UCSC; uc007mji.1; mouse. [A2A863-2] DR AGR; MGI:96613; -. DR CTD; 3691; -. DR MGI; MGI:96613; Itgb4. DR VEuPathDB; HostDB:ENSMUSG00000020758; -. DR eggNOG; KOG1226; Eukaryota. DR GeneTree; ENSGT01100000263555; -. DR HOGENOM; CLU_237558_0_0_1; -. DR InParanoid; A2A863; -. DR OrthoDB; 5475862at2759; -. DR PhylomeDB; A2A863; -. DR TreeFam; TF105392; -. DR Reactome; R-MMU-3000170; Syndecan interactions. DR Reactome; R-MMU-446107; Type I hemidesmosome assembly. DR BioGRID-ORCS; 192897; 2 hits in 63 CRISPR screens. DR ChiTaRS; Itgb4; mouse. DR PRO; PR:A2A863; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; A2A863; Protein. DR Bgee; ENSMUSG00000020758; Expressed in substantia propria of cornea and 130 other cell types or tissues. DR ExpressionAtlas; A2A863; baseline and differential. DR GO; GO:0009925; C:basal plasma membrane; IDA:MGI. DR GO; GO:0005604; C:basement membrane; IDA:MGI. DR GO; GO:0005938; C:cell cortex; ISO:MGI. DR GO; GO:0030054; C:cell junction; ISO:MGI. DR GO; GO:0031252; C:cell leading edge; ISS:UniProtKB. DR GO; GO:0009986; C:cell surface; IDA:MGI. DR GO; GO:0005925; C:focal adhesion; IBA:GO_Central. DR GO; GO:0098978; C:glutamatergic synapse; ISO:MGI. DR GO; GO:0030056; C:hemidesmosome; IDA:MGI. DR GO; GO:0008305; C:integrin complex; IDA:MGI. DR GO; GO:0031965; C:nuclear membrane; ISO:MGI. DR GO; GO:0005730; C:nucleolus; ISO:MGI. DR GO; GO:0005886; C:plasma membrane; ISO:MGI. DR GO; GO:0045211; C:postsynaptic membrane; ISO:MGI. DR GO; GO:0043235; C:receptor complex; ISO:MGI. DR GO; GO:0001664; F:G protein-coupled receptor binding; ISO:MGI. DR GO; GO:0031994; F:insulin-like growth factor I binding; IEA:Ensembl. DR GO; GO:0005178; F:integrin binding; IBA:GO_Central. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0038132; F:neuregulin binding; IEA:Ensembl. DR GO; GO:0006914; P:autophagy; ISO:MGI. DR GO; GO:0007155; P:cell adhesion; IMP:MGI. DR GO; GO:0048870; P:cell motility; ISS:UniProtKB. DR GO; GO:0007160; P:cell-matrix adhesion; ISO:MGI. DR GO; GO:0046847; P:filopodium assembly; IMP:MGI. DR GO; GO:0031581; P:hemidesmosome assembly; ISO:MGI. DR GO; GO:0007229; P:integrin-mediated signaling pathway; IBA:GO_Central. DR GO; GO:0048333; P:mesodermal cell differentiation; IEA:Ensembl. DR GO; GO:0022011; P:myelination in peripheral nervous system; IGI:MGI. DR GO; GO:0035878; P:nail development; ISO:MGI. DR GO; GO:0032290; P:peripheral nervous system myelin formation; IGI:MGI. DR GO; GO:0009611; P:response to wounding; ISS:UniProtKB. DR GO; GO:0043589; P:skin morphogenesis; ISO:MGI. DR GO; GO:0061450; P:trophoblast cell migration; IMP:MGI. DR CDD; cd00063; FN3; 4. DR Gene3D; 2.60.40.2030; -; 1. DR Gene3D; 4.10.1240.30; -; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 4. DR Gene3D; 2.10.25.10; Laminin; 3. DR Gene3D; 3.30.1680.10; ligand-binding face of the semaphorins, domain 2; 1. DR Gene3D; 2.60.40.1510; ntegrin, alpha v. Chain A, domain 3; 1. DR Gene3D; 3.40.50.410; von Willebrand factor, type A domain; 1. DR InterPro; IPR038081; CalX-like_sf. DR InterPro; IPR003644; Calx_beta. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR040622; I-EGF_1. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR033760; Integrin_beta_N. DR InterPro; IPR015812; Integrin_bsu. DR InterPro; IPR012013; Integrin_bsu-4. DR InterPro; IPR012896; Integrin_bsu_tail. DR InterPro; IPR036349; Integrin_bsu_tail_dom_sf. DR InterPro; IPR002369; Integrin_bsu_VWA. DR InterPro; IPR036465; vWFA_dom_sf. DR PANTHER; PTHR10082; INTEGRIN BETA SUBUNIT; 1. DR PANTHER; PTHR10082:SF42; INTEGRIN BETA-4; 1. DR Pfam; PF03160; Calx-beta; 1. DR Pfam; PF00041; fn3; 4. DR Pfam; PF18372; I-EGF_1; 1. DR Pfam; PF07965; Integrin_B_tail; 1. DR Pfam; PF00362; Integrin_beta; 1. DR Pfam; PF17205; PSI_integrin; 1. DR PIRSF; PIRSF002513; Integrin_B4; 1. DR PRINTS; PR01186; INTEGRINB. DR SMART; SM00237; Calx_beta; 1. DR SMART; SM00060; FN3; 4. DR SMART; SM00187; INB; 1. DR SMART; SM01242; Integrin_B_tail; 1. DR SUPFAM; SSF141072; CalX-like; 1. DR SUPFAM; SSF57196; EGF/Laminin; 2. DR SUPFAM; SSF49265; Fibronectin type III; 2. DR SUPFAM; SSF69687; Integrin beta tail domain; 1. DR SUPFAM; SSF103575; Plexin repeat; 1. DR SUPFAM; SSF53300; vWA-like; 1. DR PROSITE; PS00022; EGF_1; 2. DR PROSITE; PS01186; EGF_2; 2. DR PROSITE; PS50853; FN3; 4. DR PROSITE; PS00243; INTEGRIN_BETA; 2. DR Genevisible; A2A863; MM. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Cell adhesion; Cell junction; Cell membrane; KW Disulfide bond; EGF-like domain; Glycoprotein; Integrin; Lipoprotein; KW Magnesium; Membrane; Metal-binding; Palmitate; Phosphoprotein; Receptor; KW Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..28 FT /evidence="ECO:0000250" FT CHAIN 29..1818 FT /note="Integrin beta-4" FT /id="PRO_0000379078" FT TOPO_DOM 29..712 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 713..733 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 734..1818 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 30..74 FT /note="PSI" FT /evidence="ECO:0000255" FT DOMAIN 132..310 FT /note="VWFA" FT /evidence="ECO:0000250|UniProtKB:P05106" FT DOMAIN 458..504 FT /note="EGF-like 1" FT /evidence="ECO:0000250|UniProtKB:P05106" FT DOMAIN 505..544 FT /note="EGF-like 2" FT /evidence="ECO:0000250|UniProtKB:P05106" FT DOMAIN 545..583 FT /note="EGF-like 3" FT /evidence="ECO:0000250|UniProtKB:P05106" FT DOMAIN 584..621 FT /note="EGF-like 4" FT /evidence="ECO:0000250|UniProtKB:P05106" FT DOMAIN 981..1086 FT /note="Calx-beta" FT DOMAIN 1131..1220 FT /note="Fibronectin type-III 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 1224..1323 FT /note="Fibronectin type-III 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 1526..1621 FT /note="Fibronectin type-III 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 1639..1735 FT /note="Fibronectin type-III 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT REGION 195..200 FT /note="Involved in NRG1- and IGF1-binding" FT /evidence="ECO:0000250|UniProtKB:P16144" FT REGION 734..751 FT /note="Palmitoylated on several cysteines" FT /evidence="ECO:0000250" FT REGION 1115..1137 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1402..1433 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 473..475 FT /note="Cell attachment site" FT /evidence="ECO:0000255" FT MOTIF 1005..1007 FT /note="Cell attachment site" FT /evidence="ECO:0000255" FT BINDING 140 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /note="in MIDAS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 142 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /note="in ADMIDAS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 142 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /note="in MIDAS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 145 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /note="in ADMIDAS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 146 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /note="in ADMIDAS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 177 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /note="in LIMBS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 229 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /note="in LIMBS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 231 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /note="in LIMBS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 233 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /note="in LIMBS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 234 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /note="in LIMBS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 234 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /note="in MIDAS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT BINDING 351 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /note="in ADMIDAS binding site" FT /evidence="ECO:0000250|UniProtKB:P05106" FT MOD_RES 773 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q64632" FT MOD_RES 1071 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 1121 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q64632" FT MOD_RES 1451 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P16144" FT MOD_RES 1454 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P16144" FT MOD_RES 1470 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 1483 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P16144" FT MOD_RES 1490 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q64632" FT MOD_RES 1526 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P16144" FT MOD_RES 1787 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q64632" FT CARBOHYD 328 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 493 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 581 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 619 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 697 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 31..49 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 39..457 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 42..62 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 52..73 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 246..289 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 459..478 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 470..481 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 483..492 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 494..522 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 505..520 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 514..525 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 527..538 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 545..559 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 553..564 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 566..575 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 577..600 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 584..598 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 592..603 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 605..616 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 628..673 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 634..653 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 637..650 FT /evidence="ECO:0000250|UniProtKB:P05106" FT DISULFID 682..708 FT /evidence="ECO:0000250|UniProtKB:P05106" FT VAR_SEQ 1372..1436 FT /note="Missing (in isoform 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:8359687" FT /id="VSP_037636" FT VAR_SEQ 1515 FT /note="Q -> QGLPPIWEDGRSRLPLSWTLGSLSRAHMKGVPASRGSPDSIILAGQS FT AAPSWGT (in isoform 3)" FT /evidence="ECO:0000305" FT /id="VSP_037637" FT CONFLICT 17 FT /note="A -> R (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 67..68 FT /note="EL -> DV (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 94 FT /note="D -> V (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 113 FT /note="P -> R (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 118 FT /note="S -> T (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 624 FT /note="Missing (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 666 FT /note="Missing (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 709..713 FT /note="PPGSF -> LPAPS (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 851 FT /note="E -> K (in Ref. 3; AAH59192)" FT /evidence="ECO:0000305" FT CONFLICT 877 FT /note="T -> A (in Ref. 1 and 3; AAH06632/AAH59192)" FT /evidence="ECO:0000305" FT CONFLICT 972 FT /note="G -> S (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1105..1107 FT /note="Missing (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1204 FT /note="Q -> K (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1292 FT /note="E -> D (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1537 FT /note="P -> R (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1552 FT /note="M -> T (in Ref. 1 and 3; FT AAH06632/AAH25194/AAH59192)" FT /evidence="ECO:0000305" FT CONFLICT 1564..1566 FT /note="NGG -> TCV (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1590..1592 FT /note="HSY -> YSH (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1653 FT /note="L -> P (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1662..1663 FT /note="RP -> SR (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1744 FT /note="H -> N (in Ref. 1)" FT /evidence="ECO:0000305" FT CONFLICT 1759 FT /note="V -> M (in Ref. 3; AAH25194)" FT /evidence="ECO:0000305" SQ SEQUENCE 1818 AA; 201650 MW; CA41A7E6B4E20B59 CRC64; MAGPCCSPWV KLLLLAAMLS ASLPGDLANR CKKAQVKSCT ECIRVDKSCA YCTDELFKER RCNTQAELLA AGCRGESILV MESSLEITEN TQIDTSLHRS QVSPQGLQVR LRPGEERSFV FQVFEPLESP VDLYILMDFS NSMSDDLDNL KQMGQNLAKI LRQLTSDYTI GFGKFVDKVS VPQTDMRPEK LKEPWPNSDP PFSFKNVISL TENVEEFWNK LQGERISGNL DAPEGGFDAI LQTAVCTRDI GWRADSTHLL VFSTESAFHY EADGANVLAG IMNRNDEKCH LDASGAYTQY KTQDYPSVPT LVRLLAKHNI IPIFAVTNYS YSYYEKLHKY FPVSSLGVLQ EDSSNIVELL EEAFYRIRSN LDIRALDSPR GLRTEVTSDT LQKTETGSFH IKRGEVGTYN VHLRAVEDID GTHVCQLAKE DQGGNIHLKP SFSDGLRMDA SVICDVCPCE LQKEVRSARC HFRGDFMCGH CVCNEGWSGK TCNCSTGSLS DTQPCLREGE DKPCSGHGEC QCGRCVCYGE GRYEGHFCEY DNFQCPRTSG FLCNDRGRCS MGECVCEPGW TGRSCDCPLS NATCIDSNGG ICNGRGYCEC GRCHCNQQSL YTDTTCEINY SAIRLGLCED LRSCVQCQAW GTGEKKGRAC DDCPFKVKMV DELKKAEEVV EYCSFRDEDD DCTYSYNVEG DGSPGPNSTV LVHKKKDCPP GSFWWLIPLL IFLLLLLALL LLLCWKYCAC CKACLGLLPC CNRGHMVGFK EDHYMLRENL MASDHLDTPM LRSGNLKGRD TVRWKITNNV QRPGFATHAA STSPTELVPY GLSLRLGRLC TENLMKPGTR ECDQLRQEVE ENLNEVYRQV SGAHKLQQTK FRQQPNTGKK QDHTIVDTVL LAPRSAKQML LKLTEKQVEQ GSFHELKVAP GYYTVTAEQD ARGMVEFQEG VELVDVRVPL FIRPEDDDEK QLLVEAIDVP VGTATLGRRL VNITIIKEQA SGVVSFEQPE YSVSRGDQVA RIPVIRHILD NGKSQVSYST QDNTAHGHRD YVPVEGELLF HPGETWKELQ VKLLELQEVD SLLRGRQVRR FQVQLSNPKF GARLGQPSTT TVILGEHDET DRSLINQTLS SPPPPHGDLG APQNPNAKAA GSRKIHFNWL PPPGKPMGYR VKYWIQGDSE SEAHLLDSKV PSVELTNLYP YCDYEMKVCA YGAQGEGPYS SLVSCRTHQE VPSEPGRLAF NVVSSTVTQL SWAEPAETNG EITAYEVCYG LVNEDNRPIG PMKKVLVDNP KNRMLLIENL RESQPYRYTV KARNGAGWGP EREAIINLAT QPKRPMSIPI IPDIPIVDAQ GGEDYENFLM YSDDVLRSPA SSQRPSVSDD TGCGWKFEPL LGEELDLRRV TWRLPPELIP RLSASSGRSD EDGSVAGGVE GEGSGWIRGA TPRPPGEHLV NGRMDFAYPG SANSLHRMTA ANVAYGTHLS PHLSHRVLST SSTLTRDYHS LTRTEHSHSG TLPRDYSTLT SLSSQDSRGA VGVPDTPTRL VFSALGPTSL KVSWQEPQCD RMLLGYSVEY QLLNGGEMHR LNIPNPGQTS VVVEDLLPNH SYVFRVRAQS QEGWGREREG VITIESQVHP QSPLCPLPGS AFTLSTPSAP GPLVFTALSP DSLQLSWERP RRPNGDILGY LVTCEMAQGG APARTFRVDG DNPESRLTVP GLSENVPYKF KVQARTTEGF GPEREGIITI ESQVGGPFPQ LGSHSGLFQN PVQSEFSSVT STHSTTTEPF LMDGLTLGTQ RLEAGGSLTR HVTQEFVTRT LTASGSLSTH MDQQFFQT //